Growth Metrics

Sanofi (SNY) Change in Working Capital (2016 - 2026)

Sanofi's Change in Working Capital history spans 18 years, with the latest figure at -$406.2 million for Q1 2026.

  • On a quarterly basis, Change in Working Capital fell 302.3% to -$406.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$406.2 million, a 302.3% decrease, with the full-year FY2025 number at $317.8 million, up 337.33% from a year prior.
  • Change in Working Capital hit -$406.2 million in Q1 2026 for Sanofi, down from $2.4 billion in the prior quarter.
  • Over the last five years, Change in Working Capital for SNY hit a ceiling of $2.4 billion in Q4 2025 and a floor of -$2.5 billion in Q3 2024.
  • Historically, Change in Working Capital has averaged -$333.7 million across 5 years, with a median of -$406.2 million in 2026.
  • Biggest five-year swings in Change in Working Capital: surged 997.74% in 2022 and later tumbled 5076.5% in 2024.
  • Tracing SNY's Change in Working Capital over 5 years: stood at -$486.7 million in 2022, then soared by 145.77% to $222.7 million in 2023, then crashed by 343.26% to -$541.8 million in 2024, then surged by 550.12% to $2.4 billion in 2025, then plummeted by 116.66% to -$406.2 million in 2026.
  • Business Quant data shows Change in Working Capital for SNY at -$406.2 million in Q1 2026, $2.4 billion in Q4 2025, and $159.0 million in Q3 2025.